May 03, 2022
Investors asked an Illinois federal judge to grant final approval of a $15.5 million settlement on Monday in a class action suit against Diplomat Pharmacy Inc., which claims the company made misleading statements and failed to disclose key facts about its integration and growth before its stock price fell.